Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation

Europace

Volumn 13, Issue 12, 2011, Pages 1747-1752

  Rnn, Folke ^a,b   Kesek, Milos ^a,b   Karp, Kjell ^a,b   Henein, Michael ^a,b   Jensen, Steen M ^a,b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Atrial fibrillation; Biventricular pacing; Cardiac resynchronization; Cardiac resynchronization therapy; Congestive heart failure; Lead placement; Left ventricular pacing; Right ventricular pacing; Right ventricular pacing configurations

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ABLATION THERAPY; ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE PACING; HUMAN; ISCHEMIC HEART DISEASE; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTRODES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; STROKE VOLUME; TREATMENT OUTCOME;

EID: 81855194805     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur193     Document Type: Article

References (36)

1. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80. (Pubitemid 32224395)
2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
3. Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-5.
4. Wilkoff BL. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Card Electrophysiol Rev 2003;7:468-72.
5. Vlay SC. Right ventricular outflow tract pacing: practical and beneficial. A 9-year experience of 460 consecutive implants. Pacing Clin Electrophysiol 2006;29: 1055-62. (Pubitemid 44581392)
6. Tse HF, Yu C, Wong KK, Tsang V, Leung YL, Ho WY et al. Functional abnormalities in patients with permanent right ventricular pacing: the effect of sites of electrical stimulation. J Am Coll Cardiol 2002;40:1451-8. (Pubitemid 35192871)
7. McGavigan AD, Roberts-Thomson KC, Hillock RJ, Stevenson IH, Mond HG. Right ventricular outflow tract pacing: radiographic and electrocardiographic correlates of lead position. Pacing Clin Electrophysiol 2006;29:1063-8. (Pubitemid 44581393)
8. Mond HG, Hillock RJ, Stevenson IH, McGavigan AD. The right ventricular outflow tract: the road to septal pacing. Pacing Clin Electrophysiol 2007;30:482-91. (Pubitemid 46596124)
9. de Cock CC, Meyer A, Kamp O, Visser CA. Hemodynamic benefits of right ventricular outflow tract pacing: comparison with right ventricular apex pacing. Pacing Clin Electrophysiol 1998;21:536-41. (Pubitemid 28163106)
10. Giudici MC, Thornburg GA, Buck DL, Coyne EP, Walton MC, Paul DL et al. Comparison of right ventricular outflow tract and apical lead permanent pacing on cardiac output. Am J Cardiol 1997;79:209-12. (Pubitemid 127673716)
11. Kolettis TM, Kyriakides ZS, Tsiapras D, Popov T, Paraskevaides IA, Kremastinos DT. Improved left ventricular relaxation during short-term right ventricular outflow tract compared to apical pacing. Chest 2000;117:60-4. (Pubitemid 30053621)
12. Bourke JP, Hawkins T, Keavey P, Tynan M, Jamieson S, Behulova R et al. Evolution of ventricular function during permanent pacing from either right ventricular apex or outflow tract following AV-junctional ablation for atrial fibrillation. Europace 2002;4:219-28. (Pubitemid 36104679)
13. Mera F, DeLurgio DB, Patterson RE, Merlino JD, Wade ME, Leon AR. A comparison of ventricular function during high right ventricular septal and apical pacing after his-bundle ablation for refractory atrial fibrillation. Pacing Clin Electrophysiol 1999;22:1234-9. (Pubitemid 29382340)
14. Stambler BS, Ellenbogen K, Zhang X, Porter TR, Xie F, Malik R et al. Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:1180-6. (Pubitemid 37452886)
15. Victor F, Leclercq C, Mabo P, Pavin D, Deviller A, de Place C et al. Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing. J Am Coll Cardiol 1999; 33:311-6. (Pubitemid 29234190)
16. Hay I, Melenovsky V, Fetics BJ, Judge DP, Kramer A, Spinelli J et al. Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular nodal block. Circulation 2004;110:3404-10. (Pubitemid 39602218)
17. Bulava A, Lukl J. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems. Pacing Clin Electrophysiol 2009;32(Suppl 1):S32-7.
18. Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z et al. Effect of right ventricular lead location on response to cardiac resynchroni-zation therapy in patients with end-stage heart failure. Europace 2009; 11:356-63.
19. Riedlbauchova L, Cihak R, Bytesnik J, Vancura V, Fridl P, Hoskova L et al. Optimization of right ventricular lead position in cardiac resynchronisation therapy. Eur J Heart Fail 2006;8:609-14. (Pubitemid 44572956)
20. Leclercq C, Faris O, Tunin R, Johnson J, Kato R, Evans F et al. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 2002;106: 1760-3.
21. Gasparini M, Bocchiardo M, Lunati M, Ravazzi PA, Santini M, Zardini M et al. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: the Bi vs. Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J 2006;152:155. e1-7.
22. Sirker A, Thomas M, Baker S, Shrimpton J, Jewell S, Lee L et al. Cardiac resynchro-Nization therapy: left or left-and-right for optimal symptomatic effect-the LOLA ROSE study. Europace 2007;9:862-8. (Pubitemid 351773311)
23. De Lurgio DB, Foster E, Higginbotham MB, Larntz K, Saxon LA. A comparison of cardiac resynchronization by sequential biventricular pacing and left ventricular pacing to simultaneous biventricular pacing: rationale and design of the DECREASE-HF clinical trial. J Card Fail 2005;11:233-9. (Pubitemid 40462428)
24. Leclercq C, Ansalone G, Gadler F, Boriani G, Perez-Castellano N, Grubb N et al. Biventricular vs. Left univentricular pacing in heart failure: rationale, design, and endpoints of the B-LEFT HF study. Europace 2006;8:76-80.
25. Thakral A, Stein L, Shenai M, Gramatikov B, Thakor NV. Effects of anodal vs. cath-odal pacing on the mechanical performance of the isolated rabbit heart. J Appl Physiol 2000;89:1159-64. (Pubitemid 32125419)
26. Lloyd MS, Heeke S, Lerakis S, Langberg J. Reverse polarity pacing: the hemody-namic benefit of anodal currents at lead tips for cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2007;18:1167-71. (Pubitemid 47609875)
27. Varma N, Epstein AE, Irimpen A et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up. The Lumos-T safely reduces routine office device follow-up (TRUST) trial. Circulation 2010;122:325-32.
28. Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH, for the CONNECT Investigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) Trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 2011;57:1181-9.
29. Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009;54:1683-94.
30. Bohemer JP, Saxon LA, Lobban J, Kaplan A, Villareal L, Seth M et al. Active remote management and device monitoring in patients with HF results in frequent interventions: results from the RAPID-RF Registry. Heart Rhythm 2009;6(Suppl 5.): S76 (AB36-1).
31. Marzegalli M, Landolina M, Lunati M, Perego GB, Pappone A, Guenzati G et al. Design of the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study to assess the ability of remote monitoring to treat and triage patients more effectively. Trials 2009;10:42-52.
32. Anand IS, Greenberg BH, Fogoros RN, Libbus I, Katra RP. Design of the multi-sensor monitoring in congestive heart failure (MUSIC) study: prospective trial to assess the utility of continuous wireless physiologic monitoring in heart failure. J Card Fail 2011;17:11-6.
33. Crossley GH, Chen J, Choucair W, Cohen TJ, Gohn DC, Johnson WB et al. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol 2009;54:2012-9.
34. Ricci RP, Morichelli R, Santini M. Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care utilization. Europace 2008;10: 164-70. (Pubitemid 351767704)
35. Raatikainen MJP, Uusimaa P, van Ginneken MME, Janssen JPG, Linnaluoto M. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving and cost-effective means of follow-up. Europace 2008;10:1145-51.
36. Klersy C, De Silvestri A, Gabutti G, Raisaro A, Curti M, Regoli F et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail 2011;13:450-9.